Krishnaraj Rajalingam

23PUBLICATIONS
80CO-AUTHORS
Cell development, proliferation and deathPredictive and prognostic markersRegenerative medicine (incl. stem cells)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 20, 2026
Prohibitin 2 is a key regulator of T cell proliferation, differentiation, and effector functions in vivo.

|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth.

|Nov 18, 2025
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia.

Karin D Prummel, Kevin Woods, Maksim Kholmatov

|Oct 15, 2024
Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities.

Debomita Chakraborty, Rossana Romero, Krishnaraj Rajalingam

|Sep 30, 2024
Atypical MAPKs in cancer.

Katrin Dahm, Parthiban Vijayarangakannan, Hans-Peter Wollscheid

|Apr 14, 2023
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.

Katarzyna Bogucka-Janczi, Gregory Harms, Marie-May Coissieux

Pageof 4

Frequent Collaborators

5 joint publications

Stefan Tenzer

5 joint publications

Federico Marini

3 joint publications

Manuel Kaulich

3 joint publications

Katarzyna Bogucka-Janczi